Qing Chen
Chairman at BEIJING AOSAIKANG PHARMACEUTICAL CO., LTD.
Net worth: 464 M $ as of 31/03/2024
Profile
Qing Chen is currently the Chairman & Chief Executive Officer of Jiangsu Aosaikang Pharmaceutical Co. Ltd., Chairman of Beijing Aosaikang Pharmaceutical Co., Ltd., and General Manager & Executive Director of Nanjing Aosaikang Medical Group.
Chen holds a doctorate degree from Nanjing Medical University, a graduate degree from Zhongshan Hospital Fudan University, and an undergraduate degree from Zhenjiang Medical College.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
30/09/2022 | 317,470,588 ( 34.20% ) | 464 M $ | 31/03/2024 |
Qing Chen active positions
Companies | Position | Start |
---|---|---|
BEIJING AOSAIKANG PHARMACEUTICAL CO., LTD. | Chairman | 18/02/2019 |
Jiangsu Aosaikang Pharmaceutical Co. Ltd.
Jiangsu Aosaikang Pharmaceutical Co. Ltd. Pharmaceuticals: MajorHealth Technology Jiangsu Aosaikang Pharmaceutical Co. Ltd. develops and manufactures pharmaceutical chemicals and health-care products. It offers antibiotics and injections for the digestive, oncology, cardiovascular, and others. The company was founded on January 14, 2003 and is headquartered in Nanjing, China. | Chief Executive Officer | 01/01/2003 |
Nanjing Aosaikang Medical Group | Director/Board Member | - |
Training of Qing Chen
Nanjing Medical University | Doctorate Degree |
Zhongshan Hospital Fudan University | Graduate Degree |
Zhenjiang Medical College | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
BEIJING AOSAIKANG PHARMACEUTICAL CO., LTD. | Health Technology |
Private companies | 2 |
---|---|
Nanjing Aosaikang Medical Group | |
Jiangsu Aosaikang Pharmaceutical Co. Ltd.
Jiangsu Aosaikang Pharmaceutical Co. Ltd. Pharmaceuticals: MajorHealth Technology Jiangsu Aosaikang Pharmaceutical Co. Ltd. develops and manufactures pharmaceutical chemicals and health-care products. It offers antibiotics and injections for the digestive, oncology, cardiovascular, and others. The company was founded on January 14, 2003 and is headquartered in Nanjing, China. | Health Technology |
- Stock Market
- Insiders
- Qing Chen